Chemence Medical — Chemistry of Excellence

Wound closure in seconds. Microbial barrier for weeks.

Medical tissue adhesives & wound closure systems from Chemence Medical. From puncture wounds to 40 cm incisions — 2-Octyl Cyanoacrylate, FDA-cleared, CE-marked. Exclusively in Switzerland through ALBIN GROUP AG.

Key figures

Chemence Medical at a glance

Cyanoacrylate pioneer since 1983 — Chemence Medical has specialised in medical tissue adhesives since 1994.

40+

Years of pioneering

In cyanoacrylate specialty chemistry since 1983 — Chemence Medical since 1994

45 sec.

Tack-free with Exofin Fusion

Full cure in under 60 seconds after application

67%

Less stress damage

Thanks to the innovative Curved Mesh design of Exofin Fusion

21 days

No bacterial growth

Confirmed by in-vitro SSI test — immediate microbial barrier

Source: Chemence Medical (manufacturer data Exofin Fusion); in-vitro SSI tests; FDA 510(k) clearance.

40 years of Chemistry of Excellence

Company history

1983

Founded in London

Chemence Ltd. founded — focus on industrial adhesives and sealants.

1994

Chemence Medical

Chemence Medical Inc. founded — focus on cyanoacrylate-based medical devices.

2001

3M partnership

Development of a Consumer Liquid Bandage for 3M — marketed as Nexcare.

2005

Own FDA line

FDA-registered medical device line: Derma+Flex, Sure Close, Exofin.

2016

Exofin HV

FDA clearance for Exofin High Viscosity — the new gold standard.

2017

Exofin Fusion

FDA clearance for the Exofin Fusion Skin Closure System with Curved Mesh.

2020+

Precision Pen

Precision Pen + Curved Mesh redesign — 67% less stress load.

«Chemence is the only manufacturer of cyanoacrylate on the entire North American continent. That is a production capacity and raw-material expertise no competitor can replicate.»
Unique selling points

Why Chemence Medical?

01

40+ years of pioneering

In specialty chemistry since 1983 — Chemence Medical leading in medical adhesives since 1994.

02

Only US manufacturer

Only manufacturer of cyanoacrylate on the American continent — 100,000 m² factory in Georgia.

03

2-Octyl Cyanoacrylate

Superior compound compared with n-Butyl-CA: more flexible, more skin-friendly, stronger.

04

Highest viscosity

Exofin has the highest viscosity in the industry — no run-off.

05

Fastest polymerisation

Exofin: the fastest polymerising 2-Octyl Cyanoacrylate on the market.

06

Curved Mesh design

67% less surface stress on the wound thanks to the unique curved mesh.

07

21-day microbial barrier

Tested in vitro: no growth of SSI bacteria after 21 days.

08

Immediately shower-proof

Water-impermeable barrier — patients can shower right after surgery.

Product range

The complete wound-closure portfolio

From puncture wounds to 40 cm incisions — every wound size covered.

Exofin (1 g)

Exofin (1 g)

Gold standard

Surgical incisions, wounds

Exofin Fusion

Exofin Fusion

Revolution

Larger incisions

Form
Exofin (1 g)Liquid, Precision Pen
Exofin FusionMesh + adhesive
Viscosity:
Exofin (1 g)Highest in the industry
Exofin FusionHigh
Product features
Exofin (1 g)2-Octyl Cyanoacrylate — medically superior formulation · Highest available viscosity — no run-off · Fastest polymerisation on the market · Precision Pen applicator — maximum control · Self-puncturing closure — ready to use immediately · FDA 510(k) clearance K152476
Exofin Fusion2-component system: Curved Mesh + 2-Octyl CA adhesive · Mesh Anchors secure the net firmly to wound edges · Curved design: reduces stress load along the suture line · Short cure time for a smooth OR workflow · Antimicrobial barrier (in-vitro data) · Available in several format sizes — details in the data sheet
Indications
Exofin (1 g)Surgical incisions of all kinds, Liposuction access points (after PAL/LipoSaver), Plastic and aesthetic surgery, Minimally invasive surgery
Exofin FusionLarge incisions (tummy tuck, spinal), C-section — ideal indication, Large surgical incisions, Pre-sterilised tray — direct to the sterile field
Comparison

Tissue adhesive vs. sutures vs. staples

Tissue adhesives complement deep dermal sutures — for superficial skin closures they are the superior choice in many situations.

Chemence tissue adhesive
Chemence tissue adhesive
  • Closure timeUnder 60 seconds
  • Scar outcomeMinimal, cosmetic
  • Infection protectionImmediate microbial barrier
  • Immediately shower-proofYes — right after surgery
  • Removal required?No — sloughs off on its own
  • Pain on removalNone
  • Total costLower — no removal appointment
  • Plastic surgeryPreferred for visible sites
  • FDA/CE statusCleared for all indications
Sutures
Sutures
  • Closure timeMinutes — technically demanding
  • Scar outcomeVisible needle marks
  • Infection protectionNo intrinsic barrier
  • Immediately shower-proofNo — wound protection needed
  • Removal required?Yes — doctor appointment needed
  • Pain on removalUncomfortable to painful
  • Total costHigher — follow-up appointment
  • Plastic surgeryStandard but more scar-prone
  • FDA/CE statusStandard product
Staples
Staples
  • Closure timeFast but mechanical
  • Scar outcomeVisible staple marks
  • Infection protectionNo intrinsic barrier
  • Immediately shower-proofNo — wound protection needed
  • Removal required?Yes — special removers
  • Pain on removalUncomfortable
  • Total costHigher — follow-up
  • Plastic surgeryRare on visible sites
  • FDA/CE statusStandard product
Clinical evidence & clearances

FDA-cleared. CE-marked. Clinically proven.

FDA clearances

  • Exofin HV Tissue Adhesive: FDA 510(k) K152476 (Feb. 2016)
  • Exofin Fusion Skin Closure System: FDA clearance (Dec. 2017)
  • Derma+Flex QS: FDA-registered
  • All topical products: FDA-regulated as medical devices

Clinical studies

  • Exofin Fusion: two studies on mesh + adhesive vs. traditional methods — improved outcomes
  • In-vitro: no SSI bacterial growth after 21 days confirmed (S. aureus, MRSA, etc.)
  • Singer AJ et al.: wound tensile strength — Academic Emergency Medicine 2008
  • Bhende S et al.: microbial barrier properties — Surgical Infections 2002
For surgeons & clinics

Your wound-closure partner

Key messages for surgeons

  • Exofin HV: highest viscosity + fastest polymerisation — no product surpasses it.
  • Exofin Fusion: close a 40 cm incision in seconds — no suture kit required.
  • Immediately shower-proof: your patients leave the OR with a watertight wound seal.
  • 21-day microbial barrier: proven in vitro — reduced SSI rate, fewer readmissions.
  • ALBIN GROUP AG delivers: Chemence + PAL + MARENA + Biodermis — the complete workflow.
For patients

No suture removal. No dressing changes. Just heal.

State-of-the-art adhesive chemistry that seals and protects your wound immediately.

  • No doctor appointment for removal: the adhesive sloughs off after healing.
  • Immediately shower-proof: you can shower normally right after surgery.
  • Barely visible: the adhesive forms a transparent protective film.
  • No pain on removal: unlike sutures or staples.
  • Microbial barrier: your wound is protected against germs from the very first moment.

Exofin

Frequently asked questions

Chemence Medical

Request Chemence Medical

Request a sample kit, download the product catalogue or request a complete workflow plan (PAL + Chemence + MARENA). ALBIN GROUP AG — your exclusive partner for Chemence Medical in Switzerland.

Get in touch now